Ovid Therapeutics (OVID) Enterprise Value Growth (1y) (2017 - 2026)
Ovid Therapeutics (OVID) Enterprise Value Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -281.32% |
| Dec 31, 2025 | -32.50% |
| Sep 30, 2025 | 58.19% |
| Jun 30, 2025 | 50.18% |
| Mar 31, 2025 | 54.14% |
| Dec 31, 2024 | 49.04% |
| Sep 30, 2024 | 30.02% |
| Jun 30, 2024 | 20.25% |
| Mar 31, 2024 | 24.45% |
| Dec 31, 2023 | 18.25% |
| Sep 30, 2023 | 36.84% |
| Jun 30, 2023 | 36.65% |
| Mar 31, 2023 | 30.18% |
| Dec 31, 2022 | 32.83% |
| Sep 30, 2022 | 31.69% |
| Jun 30, 2022 | 28.20% |
| Mar 31, 2022 | 27.66% |
| Dec 31, 2021 | -160.71% |
| Sep 30, 2021 | -132.31% |
| Jun 30, 2021 | -414.38% |